Most women tracking their cycles, monitoring ovulation, and doing everything right are often surprised to learn that a small hormonal shift in the second half of their cycle could be quietly affecting conception.
A luteal phase defect rarely shows up on routine tests, yet it plays a direct role in whether an embryo successfully implants and a pregnancy holds. For women with recurrent losses or failed IVF cycles, this is often where the answers lie.
The luteal phase begins after ovulation and lasts until the next menstrual period.
LPD occurs when the corpus luteum does not produce enough progesterone. As a result, the endometrium does not develop adequately, making it difficult for an embryo to implant and grow.
A healthy luteal phase typically lasts 12 to 14 days. If it is 10 days or shorter, it is considered clinically significant and requires further evaluation.
_0.webp)
LPD is usually linked to disruptions in hormonal signaling or ovulation quality.
LPD is frequently asymptomatic, and many women only discover it after multiple failed IVF cycles or recurrent early pregnancy loss.
When symptoms are present, they may include:
For women experiencing recurrent early losses, an evaluation at a recurrent pregnancy loss clinic can help determine whether LPD is a contributing factor. In some cases, what appears to be a late period may actually be a very early pregnancy loss.
A structured hormonal and imaging workup is required to confirm a luteal phase defect.
The type of treatment of LPD is determined depending on hormonal imbalance and the reproductive goals of the individual. The objective of the treatment is the promotion of higher progesterone levels, improvement of ovulation, and preparation of the endometrium for the implantation of an embryo.
Yes. With appropriate progesterone supplementation or treatment of the underlying cause, many women with LPD conceive successfully, both naturally and through assisted reproduction.
Insufficient progesterone prevents the endometrium from adequately supporting an implanted embryo, often resulting in very early pregnancy loss before or shortly after a missed period.
Not exactly. Low progesterone is the primary indicator of LPD, but the condition also involves a shortened luteal phase and reduced endometrial receptivity, making it a broader hormonal and structural concern.
Yes. An unmanaged luteal phase defect can reduce implantation rates even with good quality embryos. Luteal phase support is therefore a non-negotiable component of all IVF protocols.